Market by Cellulite Type, Procedure Type, End-user, and Country Outlook | Forecast 2023-2030
According to Triton Market Research’s report, the cellulite treatment market in the Asia-Pacific region is expected to grow at a compound annual growth rate of 9.83% between the forecast years 2023 and 2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
studied region comprises countries such as:
•
China
•
Japan
•
South Korea
•
India
•
Australia & New Zealand
•
ASEAN Countries
•
Rest of Asia-Pacific
India has established itself as a prominent
player in the cellulite treatment market, expected to witness the fastest
growth. This growth is
fueled by the increasing number of aesthetic procedures and a large pool of
qualified medical professionals in the country. Moreover, the high prevalence
of obesity and a rapidly growing elderly population are expected to surge the
demand for cellulite treatments. India is also known for providing affordable
treatment options, making it an attractive destination for medical tourism. As
the medical tourism industry continues to grow, it is expected to further boost
the demand for various procedures. Given the above-stated factors, India is
poised to continue its growth trajectory in the cellulite treatment market.
South Korea’s beauty industry has gained
significant prominence globally, owing to innovative ingredients and appealing
packaging. In 2020, the cosmetics sector in the country was estimated to be
worth $6.8 billion. Additionally, the nation has a significant number of
plastic surgeons, with approximately 2,600 professionals operating in 2021. The
quality of healthcare services available is expected to be a
major driver of market growth as consumers prioritize safety and effectiveness
when choosing beauty treatments. Moreover, the rising awareness about cosmetic
treatments and the increasing number of individuals focused on their appearance
are expected to further propel the South Korean cellulite treatment market
growth during the forecast period.
Minimally invasive procedures refer to a range
of surgical techniques that are designed to minimize the size of surgical
incisions. This approach provides numerous benefits, including faster wound
healing times, reduced risk of infections, and decreased post-surgical pain. The market’s growth is determined based on
procedure type, cellulite type, and end-user. The procedure type segment
includes non-invasive, minimally invasive, and topical.
The
eminent companies in the market include Candela Medical Corporation, Endo
International Plc, AbbVie Inc, Galderma SA, and Cutera Inc.
Galderma SA is a Switzerland-based dermatology company with a global
presence across Latin America, Europe, the Middle East, Africa, North America,
and Asia-Pacific. It specializes in science-based solutions and medical
services for skin health, providing effective and reliable products and
services that cater to diverse needs. One of the company’s products is
Sculptra, a treatment that utilizes the skin’s natural ability to renew collagen
production and achieve a more youthful appearance.
Key deliverables of the report:
● Market CAGR during the forecasting years 2023-2030
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the cellulite treatment market revenue growth in the Asia-Pacific and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the APAC
cellulite treatment market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Category, Applicatio ..
VIEW REPORT
Market by RTD Type | Forecast ..
VIEW REPORT
Market by Product Type | Forec ..
VIEW REPORT
Market by Product, Application ..
VIEW REPORT
Market By Product Type, Specie ..
VIEW REPORT
Market by Ingredient Type, Age ..
VIEW REPORT
Market By Demographics, Produc ..
VIEW REPORT
Market by Type, Sales Channel, ..
VIEW REPORT1. ASIA-PACIFIC
CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.PARENT
MARKET ANALYSIS
2.2.IMPACT
ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19
IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA
WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S
FIVE FORCES ANALYSIS
2.3.1.THREAT
OF NEW ENTRANTS
2.3.2.THREAT
OF SUBSTITUTES
2.3.3.BARGAINING
POWER OF BUYERS
2.3.4.BARGAINING
POWER OF SUPPLIERS
2.3.5.THREAT
OF COMPETITIVE RIVALRY
2.4.MARKET
MATURITY ANALYSIS
2.5.INDUSTRY
COMPONENTS
2.5.1.RESEARCH
AND DEVELOPMENT
2.5.2.MANUFACTURING
OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES
MONITORING
2.6.REGULATORY
FRAMEWORK
2.7.KEY
BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND
NAME
2.7.3.USABILITY
2.8.KEY
MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT
LAUNCHES
2.8.3.MERGERS
& ACQUISITIONS
2.8.4.BUSINESS
DIVESTITURES & EXPANSIONS
2.9.MARKET
DRIVERS
2.9.1.GROWING
PREVALENCE OF OBESITY
2.9.2.RAPIDLY
GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING
DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET
CHALLENGES
2.10.1.LACK
OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH
PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS
ASSOCIATED POST-TREATMENT
2.11.MARKET
OPPORTUNITIES
2.11.1.RISING
BEAUTY CONSCIOUSNESS
2.11.2.INCREASING
TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING
DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING
POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS
IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST
PERSPECTIVE
3. ASIA-PACIFIC
CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT
CELLULITE
3.2.HARD
CELLULITE
3.3.EDEMATOUS
CELLULITE
4. ASIA-PACIFIC
CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY
INVASIVE
4.3.TOPICAL
5. ASIA-PACIFIC
CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS
AND BEAUTY CENTERS
5.3.OTHER
END-USERS
6. ASIA-PACIFIC
CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY
ANALYSIS
6.1.1.CHINA
6.1.1.1.CHINA
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.JAPAN
6.1.2.1.JAPAN
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.INDIA
6.1.3.1.INDIA
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.SOUTH
KOREA
6.1.4.1.SOUTH
KOREA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.5.ASEAN
COUNTRIES
6.1.5.1.ASEAN
COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.6.AUSTRALIA
& NEW ZEALAND
6.1.6.1.AUSTRALIA
& NEW ZEALAND CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.7.REST
OF ASIA-PACIFIC
6.1.7.1.REST
OF ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1.JOHNSON
& JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT
PORTFOLIO
7.1.3.KEY
STRENGTHS
7.1.4.KEY
CHALLENGES
7.2.ABBVIE
INC
7.2.1.OVERVIEW
7.2.2.PRODUCT
PORTFOLIO
7.2.3.KEY
STRENGTHS
7.2.4.KEY
CHALLENGES
7.3.BAUSCH
HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT
PORTFOLIO
7.3.3.KEY
STRENGTHS
7.3.4.KEY
CHALLENGES
7.4.CUTERA
INC
7.4.1.OVERVIEW
7.4.2.PRODUCT
PORTFOLIO
7.4.3.KEY
STRENGTHS
7.4.4.KEY
CHALLENGES
7.5.INCELER
MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT
PORTFOLIO
7.5.3.KEY
STRENGTHS
7.5.4.KEY
CHALLENGES
7.6.ZIMMER
MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT
PORTFOLIO
7.6.3.KEY
STRENGTHS
7.6.4.KEY
CHALLENGES
7.7.GALDERMA
SA
7.7.1.OVERVIEW
7.7.2.PRODUCT
PORTFOLIO
7.7.3.KEY
STRENGTHS
7.7.4.KEY
CHALLENGES
7.8.SIENTRA
INC
7.8.1.OVERVIEW
7.8.2.PRODUCT
PORTFOLIO
7.8.3.KEY
STRENGTHS
7.8.4.KEY
CHALLENGES
7.9.ENDO
INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT
PORTFOLIO
7.9.3.KEY
STRENGTHS
7.9.4.KEY
CHALLENGES
7.10.CANDELA
MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT
PORTFOLIO
7.10.3.KEY
STRENGTHS
7.10.4.KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1.RESEARCH
SCOPE & DELIVERABLES
8.1.1.OBJECTIVES
OF STUDY
8.1.2.SCOPE
OF STUDY
8.2.SOURCES
OF DATA
8.2.1.PRIMARY
DATA SOURCES
8.2.2.SECONDARY
DATA SOURCES
8.3.RESEARCH
METHODOLOGY
8.3.1.EVALUATION
OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION
OF DATA SOURCES
8.3.3.ASSESSMENT
OF MARKET DETERMINANTS
8.3.4.DATA
COLLECTION
8.3.5.DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF
PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS
& ACQUISITIONS
TABLE 6: LIST OF
BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: MARKET
MATURITY ANALYSIS
FIGURE 2: INDUSTRY
COMPONENTS
FIGURE 3: KEY BUYING
IMPACT ANALYSIS
FIGURE 4: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $
MILLION)
FIGURE 14: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: CHINA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: JAPAN CELLULITE
TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: INDIA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: SOUTH KOREA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: ASEAN
COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: AUSTRALIA
& NEW ZEALAND CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: REST OF
ASIA-PACIFIC CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)